Education
About Us
Working with TipRanks
Follow Us
Miller Timothy J Insider Profile
4 Followers
Miller Timothy J, President & Chief Scientific Officer at Abeona Therapeutics, holds ― shares in Abeona Therapeutics (Ticker: ABEO), holds 87.50K shares in RDE (Ticker: GIFT). Most recently, Miller Timothy J ― shares of Abeona Therapeutics on ― for an estimated value of ―.
Miller Timothy J has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Miller Timothy J holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Miller Timothy J
Miller Timothy J's Trading History
Abeona Therapeutics
―
President & Chief Scientific Officer
―
―
RDE
Jun 06, 2025
Vice President, Sales
Uninformative Buy
23.07K
$102.37K
List of latest transactions for each holding click on a transaction to see Miller Timothy J's performance on stock
You May Also Like
Miller Timothy J insider profile FAQ
What is the percentage of profitable transactions made by Miller Timothy J?
The percentage of profitable transactions made by Miller Timothy J is ―.
What is the average return per transaction made by Miller Timothy J?
The average return per transaction made by Miller Timothy J is ―.
What stocks does Miller Timothy J hold?
Miller Timothy J holds: ABEO, GIFT stocks.
What was Miller Timothy J’s latest transaction?
Miller Timothy J latest transaction was an Uninformative Buy of ―.
What was Miller Timothy J's most profitable transaction?
Miller Timothy J’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Miller Timothy J's role in Abeona Therapeutics?
Miller Timothy J's role in Abeona Therapeutics is President & Chief Scientific Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.